ReleaseWire Connect

An investigation on behalf of investors of Repros Therapeutics Inc (NASDAQ:RPRX) shares over potential securities laws violations by Repros Therapeutics Inc and certain of its directors and officers in connection certain statements over its Androxal was announced.

An investor, who currently hold shares of Tellabs, Inc. (NASDAQ:TLAB), filed a lawsuit in effort to halt the proposed takeover of Tellabs, Inc. by Marlin Equity Partners for $2.45 per NASDAQ:TLAB share.

An investigation on behalf of investors, who purchased shares of Farmer Brothers Co. (NASDAQ:FARM) shares, was announced concerning whether certain Farmer Brothers officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investor, who purchased shares of Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), filed a lawsuit in the U.S. District Court for the Southern District of Florida over alleged violations of Federal Securities Laws by Catalyst Pharmaceutical Partners, Inc. in connection with certain allegedly false and misleading statements made between October 31, 2012 and October 18, 2013

An investor, who purchased shares of Pretium Resources Inc (NYSE:PVG), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Pretium Resources Inc in connection with certain allegedly false and misleading statements made between January 9, 2012 and October 21, 2013regarding the Company's mineral reserves and compliance with applicable reporting and feasibility study requirements.

An investigation on behalf of investors, who currently hold shares of Cole Real Estate Investments Inc (NYSE:COLE) shares, was announced concerning whether the takeover of Cole Real Estate Investments Inc by American Realty Capital Properties is unfair to NYSE:COLE stockholders.

An investigation on behalf of investors of Abbott Laboratories (NYSE:ABT) shares over potential securities laws violations by Abbott Laboratories and certain of its directors and officers in connection certain financial statements was announced.

An investigation for investors who purchased shares of Saba Software, Inc. (formerly NASDAQ:SABA, now OTCMKTS:SABA) was announced concerning potential violations of Federal Securities Laws by Saba Software, Inc.

An investor who holds shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) filed a lawsuit against directors of Peregrine Pharmaceuticals in connection with allegedly excessive compensation.

An investor, who purchased shares of Valley Forge Composite Technologies, Inc (OTCMKTS:VLYF), filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Valley Forge Composite Technologies, Inc in connection with certain allegedly false and misleading statements made between January 1, 2009 and February 6, 2013